Pharmacopsychiatry 2005; 38(4): 178-179
DOI: 10.1055/s-2005-871241
Letter
A Case Report
© Georg Thieme Verlag Stuttgart · New York

Clioquinol Treatment in Familiar Early Onset of Alzheimer’s Disease

A Case ReportB. Ibach1 , E. Haen1 , J. Marienhagen2 , G. Hajak1
  • 1Department of Psychiatry and Psychotherapy (Director: Prof. Dr. H. E. Klein), University of Regensburg, Universitätsstraße 84, Regensburg, Germany
  • 2Department of Nuclear Medicine (Director: Prof. Dr. C. Eilles), University of Regensburg, Universitätsstraße 84, Regensburg, Germany
Weitere Informationen

Publikationsverlauf

Received: 31.8.2004 Revised: 1.12.2004

Accepted: 10.1.2005

Publikationsdatum:
18. Juli 2005 (online)

Preview

Recently the metal chelator clioquinol (CQ) has been suggested as a possible option for treatment of Alzheimer’s disease (AD). We report two patients with early onset of AD [one with a mutant amyloid-precursor-protein (APP) gene] who received long-term treatment with CQ. In both cases focally augmented cerebral glucose metabolism and stabilization but no amelioration of the clinical impression were observed without signs of neurotoxicity. In one case CSF-tau and β-Amyloid42/40 concentrations changed during CQ treatment.

References

Bernd Ibach, MD

Memory Disorders Clinic

Geriatric Psychiatry Research Group

Department of Psychiatry and Psychotherapy

University of Regensburg

Universitätsstraße 84

93953 Regensburg

Germany

Telefon: +49 941 941 1221/2063

Fax: +49 941 2079

eMail: bernd.ibach@ klinik.uni-regensburg.de